sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
»ùÒòÐÞÊξ«ÉñÆÆËéÖ¢¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Éñ¾­ÏµÍ³Ä£×Ó > »ùÒòÐÞÊξ«ÉñÆÆËéÖ¢¶¯ÎïÄ£×Ó

ǰÑÔ

¾«ÉñÆÆËéÖ¢±»Ö¤ÊµÎªÒ»Öָ߶ÈÒÅ´«ÐÔ¼²²¡£¬»ùÒòÇóýºÍת»ùÒòÊÖÒÕΪ¾«ÉñÆÆËéÖ¢ÐÂÒ»´ú¶¯ÎïÄ£×ӵĽ¨ÉèµÓÚ¨ÁË»ù´¡¡£ÏÖÔÚÑо¿½ÏÁ¿³ÉÊìµÄÊÇMDAÊÜÌåºÍNMDAÊÜÌåÑÇ»ùNR1Ä£×Ó¡£

?

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

»ùÒòÐÞÊζ¯ÎïÄ£×ÓÖ÷ÒªÕë¶ÔÔÚÉñ¾­·¢ÓýÖÐÆð×÷ÓõĻùÒò£¬Èçάϵϸ°û¼äÅþÁ¬ºÍÓªÑøÒò×ӵȡ£Éñ¾­Ï¸°û𤸽·Ö×Ó180(neural cell adhesion molecule,NCAM-180)»ùÒòÇóýСÊóÔòÊǸıäÁËÉñ¾­ÔªÇ¨áãÀú³ÌÖÐʩչ×÷ÓõĻùÒò±í´ï¡£±ðµÄ£¬Æ¾Ö¤·Ö×ӽṹ²î±ð£¬NMDAÊÜÌåÓÉNR1¡¢NR2A-DÁ½¸öÑÇ»ù×é³É£¬Í¨¹ýÒÅ´«¹¤³Ì»ñµÃNR1»ùÒòÇóýNr1 neo-/-СÊóÄ£×Ó¡£

¡¾Ä£×ÓÌØµã¡¿£º

NCAM-180ÇóýÊóСµÄÍÙÒºËᣭCAM (PSA-NCAM)ˮƽÏÔ׎µµÍ¡£¶ø¾«ÉñÆÆËéÖ¢º£ÂíÖÐÒ²ÓÐPSA-NCAMˮƽÏÔ׎µµÍ¡£Í¬Ê±£¬¸ÃСÊó»¹ÌåÏÖΪÐáÇò¡¢º£ÂíºÍСÄԵȼ¸¸öÄÔÇøÏ¸°û½á¹¹¸Ä±ä¡¢ÄÔÊÒÀ©´óºÍÐÐΪÒì³£µÈ¡£NR1»ùÒòÇóýСÊóÌåÏÖ³öÀྫÉñÆÆËéÖ¢µÄÑôÐÔÖ¢×´£¨×Ô¾õÐÔÔ˶¯ÔöÇ¿£©ÓëÒõÐÔÖ¢×´£¨Éç»áÐÔÐÐΪÍËËõ£©£¬Ç°ÕßÔÚµ¥´Îßß·úऴ¼ºÍÂȵªÆ½¸øÒ©ºó»ñµÃ»º½â£¬ºóÕßÔÚµªÆ½¼±ÐÔ¸øÒ©ºóÖ¢×´µÃÒÔÄæ×ª¡£ÖµµÃ×¢ÖØ£¬´Ë»ùÒò±äÒìСÊóÎÆ×´Ìå´¦µÄDAÊÜÌ弰ϸ°ûÍâDAˮƽûÓÐÌåÏÖ³öÒì³££¬Òò´ËÒÑÍùÒÔΪNMDAÊÜÌåÞ׿¹¼ÁÊÇͨ¹ýÔöÌíDAÊÍ·ÅÌåÏÖ³öÆäÐÐΪЧ¹ûµÄ¿´·¨Óдý½øÒ»²½È·Ö¤¡£µ«Ò²ËµÃ÷ÎúDAÓëNMDAÉñ¾­´«µ¼µÄÏ໥×÷Óò»ÊÇÔÚÍ»´¥Ç°DAÊÜÌåˮƽ£¬¶øÊÇÔÚÍ»³öºóDAÊÜÌåˮƽÉϵÄ¡£ÁíÍ⣬ÔÚ˲ĿʵÑéÖÐÒ²ÓÐÒì³£¡£ßß·úऴ¼ºÍÀûÅàͪÄܹ»¼õÇá¸ÃСÊóµÄÔ˶¯ÔöÇ¿ÐÐΪ¡£ÕâЩСÊóµÄǰ¶îÒ¶ºÍÎÆ×´Ìå¿É¼ûÖеÈˮƽµÄDAºÍ5-HT´úл¸Ä±ä¡£¶øÎÆ×´ÌåÇÐÆ¬ÉÏNMDA´Ì¼¤µÄDAÊÍ·ÅÔöÌí£¬GABAÊÍ·ÅÔòÃ÷ÏÔïÔÌ­¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

¶Ô¹È°±Ëá½éµ¼µÄÉñ¾­´«µ¼ÏµÍ³»ùÒòÄ£×ÓµÄÑо¿£¬Îª½øÒ»²½ÆÊÎö¾«ÉñÆÆËéÖ¢µÄ·¢²¡»úÖÆÌṩÁËÁÉÀ«µÄÔ¶¾°¡£

?

²Î¿¼ÎÄÏ×£º

1.ÍõÏþÁ¼£®´Þ¶«ºì£¬ËÚÓ×áÔ£®¶¯ÎïÄ£×ÓÔÚ¾«ÉñÆÆËéÖ¢Ñо¿ÖеÄÓ¦ÓÃÓëÏ£Íû£®ÖйúÒ½Ò©µ¼±¨£¬2012,9 (30):23-26

2.ÀîÏþ°×£¬·½êÝÈ壬Íõ׿³Ð£¬µÈ£®¾«ÉñÆÆËéÖ¢¶¯ÎïÄ£×ÓÑо¿Ï£Íû£®ÉϺ£¾«Éñҽѧ£¬2004, 16(3): 184-186

3.Bertaina-Anglade V,Enjuanes E,Morillon D,el al. The object recognition Lask in rats anrl mice:a simple and rapid model in safety pharmacology lo detect amnesi properties of a new chemical entity. J Pharmacol Toxicol Methods, 2006, 54 (2):99-105

4.Jentsch JD, Roth RH. The neuropsypharmacology of phencyclidine: from NMDA receptor ?hypofunction ?lo the dopamine hypothesis of schizophrenia. Neurops-ychopharmacology, 1999,20 (3):201 -225

5.Kilts CD. The changing roles and targets for animal models of schizophrenia. Biol psychosis, 2001, 50 (11):845-855

6.Li Q,Cheung C, Wei R,el al. Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant lo schizophrenia:evidence from MRI in a mouse model. PLoS One,2009,4(7):e6354

7.Semenova S,Ceyer MA,Sutcliffe JC,et al. Inaclivalion of the 5-HT7 receptor partiality blocks phencyclidineinduced disruption of prepulse inhibition. Biol Psychiatry, 2008, 63 (1):98-105

8.van Elst LT, Valerius G,Buchert M,et al. Incrased prefrontal and hippocampal glutamate ?concentration in schizophrenia:evidence from a magnetic resonance pectroscopy study. Biol Psychiatry, 2005,58 (9):724-730

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Éñ¾­ÏµÍ³Ä£×Ó > »ùÒòÐÞÊξ«ÉñÆÆËéÖ¢¶¯ÎïÄ£×Ó
»ùÒòÐÞÊξ«ÉñÆÆËéÖ¢¶¯ÎïÄ£×Ó

ǰÑÔ

¾«ÉñÆÆËéÖ¢±»Ö¤ÊµÎªÒ»Öָ߶ÈÒÅ´«ÐÔ¼²²¡£¬»ùÒòÇóýºÍת»ùÒòÊÖÒÕΪ¾«ÉñÆÆËéÖ¢ÐÂÒ»´ú¶¯ÎïÄ£×ӵĽ¨ÉèµÓÚ¨ÁË»ù´¡¡£ÏÖÔÚÑо¿½ÏÁ¿³ÉÊìµÄÊÇMDAÊÜÌåºÍNMDAÊÜÌåÑÇ»ùNR1Ä£×Ó¡£

?

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

»ùÒòÐÞÊζ¯ÎïÄ£×ÓÖ÷ÒªÕë¶ÔÔÚÉñ¾­·¢ÓýÖÐÆð×÷ÓõĻùÒò£¬Èçάϵϸ°û¼äÅþÁ¬ºÍÓªÑøÒò×ӵȡ£Éñ¾­Ï¸°û𤸽·Ö×Ó180(neural cell adhesion molecule,NCAM-180)»ùÒòÇóýСÊóÔòÊǸıäÁËÉñ¾­ÔªÇ¨áãÀú³ÌÖÐʩչ×÷ÓõĻùÒò±í´ï¡£±ðµÄ£¬Æ¾Ö¤·Ö×ӽṹ²î±ð£¬NMDAÊÜÌåÓÉNR1¡¢NR2A-DÁ½¸öÑÇ»ù×é³É£¬Í¨¹ýÒÅ´«¹¤³Ì»ñµÃNR1»ùÒòÇóýNr1 neo-/-СÊóÄ£×Ó¡£

¡¾Ä£×ÓÌØµã¡¿£º

NCAM-180ÇóýÊóСµÄÍÙÒºËᣭCAM (PSA-NCAM)ˮƽÏÔ׎µµÍ¡£¶ø¾«ÉñÆÆËéÖ¢º£ÂíÖÐÒ²ÓÐPSA-NCAMˮƽÏÔ׎µµÍ¡£Í¬Ê±£¬¸ÃСÊó»¹ÌåÏÖΪÐáÇò¡¢º£ÂíºÍСÄԵȼ¸¸öÄÔÇøÏ¸°û½á¹¹¸Ä±ä¡¢ÄÔÊÒÀ©´óºÍÐÐΪÒì³£µÈ¡£NR1»ùÒòÇóýСÊóÌåÏÖ³öÀྫÉñÆÆËéÖ¢µÄÑôÐÔÖ¢×´£¨×Ô¾õÐÔÔ˶¯ÔöÇ¿£©ÓëÒõÐÔÖ¢×´£¨Éç»áÐÔÐÐΪÍËËõ£©£¬Ç°ÕßÔÚµ¥´Îßß·úऴ¼ºÍÂȵªÆ½¸øÒ©ºó»ñµÃ»º½â£¬ºóÕßÔÚµªÆ½¼±ÐÔ¸øÒ©ºóÖ¢×´µÃÒÔÄæ×ª¡£ÖµµÃ×¢ÖØ£¬´Ë»ùÒò±äÒìСÊóÎÆ×´Ìå´¦µÄDAÊÜÌ弰ϸ°ûÍâDAˮƽûÓÐÌåÏÖ³öÒì³££¬Òò´ËÒÑÍùÒÔΪNMDAÊÜÌåÞ׿¹¼ÁÊÇͨ¹ýÔöÌíDAÊÍ·ÅÌåÏÖ³öÆäÐÐΪЧ¹ûµÄ¿´·¨Óдý½øÒ»²½È·Ö¤¡£µ«Ò²ËµÃ÷ÎúDAÓëNMDAÉñ¾­´«µ¼µÄÏ໥×÷Óò»ÊÇÔÚÍ»´¥Ç°DAÊÜÌåˮƽ£¬¶øÊÇÔÚÍ»³öºóDAÊÜÌåˮƽÉϵÄ¡£ÁíÍ⣬ÔÚ˲ĿʵÑéÖÐÒ²ÓÐÒì³£¡£ßß·úऴ¼ºÍÀûÅàͪÄܹ»¼õÇá¸ÃСÊóµÄÔ˶¯ÔöÇ¿ÐÐΪ¡£ÕâЩСÊóµÄǰ¶îÒ¶ºÍÎÆ×´Ìå¿É¼ûÖеÈˮƽµÄDAºÍ5-HT´úл¸Ä±ä¡£¶øÎÆ×´ÌåÇÐÆ¬ÉÏNMDA´Ì¼¤µÄDAÊÍ·ÅÔöÌí£¬GABAÊÍ·ÅÔòÃ÷ÏÔïÔÌ­¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

¶Ô¹È°±Ëá½éµ¼µÄÉñ¾­´«µ¼ÏµÍ³»ùÒòÄ£×ÓµÄÑо¿£¬Îª½øÒ»²½ÆÊÎö¾«ÉñÆÆËéÖ¢µÄ·¢²¡»úÖÆÌṩÁËÁÉÀ«µÄÔ¶¾°¡£

?

²Î¿¼ÎÄÏ×£º

1.ÍõÏþÁ¼£®´Þ¶«ºì£¬ËÚÓ×áÔ£®¶¯ÎïÄ£×ÓÔÚ¾«ÉñÆÆËéÖ¢Ñо¿ÖеÄÓ¦ÓÃÓëÏ£Íû£®ÖйúÒ½Ò©µ¼±¨£¬2012,9 (30):23-26

2.ÀîÏþ°×£¬·½êÝÈ壬Íõ׿³Ð£¬µÈ£®¾«ÉñÆÆËéÖ¢¶¯ÎïÄ£×ÓÑо¿Ï£Íû£®ÉϺ£¾«Éñҽѧ£¬2004, 16(3): 184-186

3.Bertaina-Anglade V,Enjuanes E,Morillon D,el al. The object recognition Lask in rats anrl mice:a simple and rapid model in safety pharmacology lo detect amnesi properties of a new chemical entity. J Pharmacol Toxicol Methods, 2006, 54 (2):99-105

4.Jentsch JD, Roth RH. The neuropsypharmacology of phencyclidine: from NMDA receptor ?hypofunction ?lo the dopamine hypothesis of schizophrenia. Neurops-ychopharmacology, 1999,20 (3):201 -225

5.Kilts CD. The changing roles and targets for animal models of schizophrenia. Biol psychosis, 2001, 50 (11):845-855

6.Li Q,Cheung C, Wei R,el al. Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant lo schizophrenia:evidence from MRI in a mouse model. PLoS One,2009,4(7):e6354

7.Semenova S,Ceyer MA,Sutcliffe JC,et al. Inaclivalion of the 5-HT7 receptor partiality blocks phencyclidineinduced disruption of prepulse inhibition. Biol Psychiatry, 2008, 63 (1):98-105

8.van Elst LT, Valerius G,Buchert M,et al. Incrased prefrontal and hippocampal glutamate ?concentration in schizophrenia:evidence from a magnetic resonance pectroscopy study. Biol Psychiatry, 2005,58 (9):724-730

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿